EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study

Maho Suzukawa, Ken Ohta, Masahiro Sugimoto, Nobuharu Ohshima, Nobuyuki Kobayashi, Hiroyuki Tashimo, Yasushi Tanimoto, Junko Itano, Goro Kimura, Shohei Takata, Takako Nakano, Takafumi Yamashita und 7 weitere

Allergology International · 2024

DOI: 10.1016/j.alit.2024.04.003 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Allergology International, 2024. Verfasst von Maho Suzukawa und 18 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan. Electronic address: suzukawamaho@gmail.com. Hauptthemen laut MEDLINE: Asthma, Volatile Organic Compounds, Phenotype, Breath Tests. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GlaxoSmithKline Plc, GlaxoSmithKline Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Asthma is characterized by phenotypes of different clinical, demographic, and pathological characteristics. Identifying the profile of exhaled volatile organic compounds (VOCs) in asthma phenotypes may facilitate establishing biomarkers and understanding asthma background pathogenesis. This study aimed to identify exhaled VOCs that characterize severe asthma phenotypes among patients with asthma. METHODS: This was a multicenter cross-sectional study of patients with severe asthma in Japan. Clinical data were obtained from medical records, and questionnaires were collected. Exhaled breath was sampled and subjected to thermal desorption gas chromatography-mass spectrometry (GC/MS). RESULTS: Using the decision tree established in the previous nationwide asthma cohort study, 245 patients with asthma were divided into five phenotypes and subjected to exhaled VOC analysis with 50 healthy controls (HCs). GC/MS detected 243 VOCs in exhaled breath samples, and 142 frequently detected VOCs (50% of all samples) were used for statistical analyses. Cluster analysis assigning the groups with similar VOC profile patterns showed the highest similarities between phenotypes 3 and 4 (early-onset asthma phenotypes), followed by the similarities between phenotypes 1 and 2 (late-onset asthma phenotypes). Comparisons between phenotypes 1-5 and HC revealed 19 VOCs, in which only methanesulfonic anhydride showed p < 0.05 adjusted by false discovery rate (FDR). Comparison of these phenotypes yielded several VOCs showing different trends (p < 0.05); however, no VOCs showed p < 0.05 adjusted by FDR. CONCLUSIONS: Exhaled VOC profiles may be useful for distinguishing asthma and asthma phenotypes; however, these findings need to be validated, and their pathological roles should be clarified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaVolatile Organic CompoundsPhenotypeBreath TestsExhalationHumansMaleFemaleMiddle AgedCross-Sectional StudiesAdultBiomarkersGas Chromatography-Mass SpectrometryAgedJapan

Stichwörter der Autor:innen

AsthmaCluster analysisExhaled breathPhenotypeVolatile organic compounds

Substanzen

Volatile Organic CompoundsBiomarkers

Autor:innen und Institutionen

  • Clinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan. Electronic address: suzukawamaho@gmail.com.
  • Clinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan; Japan Anti-Tuberculosis Association, JATA Fukujuji Hospital, Tokyo, Japan. Electronic address: kenohta3@gmail.com.
  • Institute for Advanced Biosciences, Keio University, Yamagata, Japan; Human Metabolome Technologies, Inc., Yamagata, Japan.
  • Clinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
  • National Hospital Organization Minami-Okayama Medical Center, Okayama, Japan.
  • National Hospital Organization Fukuokahigashi Medical Center, Fukuoka, Japan.

Förderung

  • GlaxoSmithKline Plc
  • GlaxoSmithKline Japan

Zitieren

APA

Suzukawa, M., Ohta, K., Sugimoto, M., Ohshima, N., Kobayashi, N., Tashimo, H., Tanimoto, Y., Itano, J., Kimura, G., Takata, S., Nakano, T., Yamashita, T., Ikegame, S., Hyodo, K., Abe, M., Chibana, K., Kamide, Y., Sasaki, K., & Hashimoto, H. (2024). Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study. Allergology International. https://doi.org/10.1016/j.alit.2024.04.003

Vancouver

Suzukawa M, Ohta K, Sugimoto M, Ohshima N, Kobayashi N, Tashimo H, et al. Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study. Allergology International. 2024. doi:10.1016/j.alit.2024.04.003

BibTeX
@article{Suzukawa2024,
  author = {Suzukawa, Maho and Ohta, Ken and Sugimoto, Masahiro and Ohshima, Nobuharu and Kobayashi, Nobuyuki and Tashimo, Hiroyuki and Tanimoto, Yasushi and Itano, Junko and Kimura, Goro and Takata, Shohei and Nakano, Takako and Yamashita, Takafumi and Ikegame, Satoshi and Hyodo, Kentaro and Abe, Masahiro and Chibana, Kenji and Kamide, Yosuke and Sasaki, Kazunori and Hashimoto, Hiroya},
  title = {Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study},
  journal = {Allergology International},
  year = {2024},
  doi = {10.1016/j.alit.2024.04.003}
}
Kostenlos starten →